| pubmed-article:18641082 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C2349001 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C0001924 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C0681850 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C1706203 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C2697811 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C0221102 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C0022646 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C0022661 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C0403447 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
| pubmed-article:18641082 | lifeskim:mentions | umls-concept:C1550501 | lld:lifeskim |
| pubmed-article:18641082 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:18641082 | pubmed:dateCreated | 2008-11-25 | lld:pubmed |
| pubmed-article:18641082 | pubmed:abstractText | The Kidney Disease Outcomes Quality Initiative guidelines aim to define chronic kidney disease (CKD) and classify its stages. Stage 3 CKD generally receives more attention than stage 1 or 2, because the more impaired glomerular filtration rate (GFR) in stage 3 suggests a higher cardiovascular and renal risk. In this study we evaluated cardiovascular and renal outcome in subjects with stage 1 and 2 CKD. For comparison, we also studied these outcomes in stage 3 CKD. | lld:pubmed |
| pubmed-article:18641082 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18641082 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18641082 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18641082 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18641082 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18641082 | pubmed:issn | 1460-2385 | lld:pubmed |
| pubmed-article:18641082 | pubmed:author | pubmed-author:de JongPaul... | lld:pubmed |
| pubmed-article:18641082 | pubmed:author | pubmed-author:PREVEND... | lld:pubmed |
| pubmed-article:18641082 | pubmed:author | pubmed-author:de ZeeuwDickD | lld:pubmed |
| pubmed-article:18641082 | pubmed:author | pubmed-author:HillegeHans... | lld:pubmed |
| pubmed-article:18641082 | pubmed:author | pubmed-author:BakkerStephan... | lld:pubmed |
| pubmed-article:18641082 | pubmed:author | pubmed-author:BrantsmaAuke... | lld:pubmed |
| pubmed-article:18641082 | pubmed:author | pubmed-author:GansevoortRon... | lld:pubmed |
| pubmed-article:18641082 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18641082 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:18641082 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18641082 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18641082 | pubmed:pagination | 3851-8 | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:meshHeading | pubmed-meshheading:18641082... | lld:pubmed |
| pubmed-article:18641082 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18641082 | pubmed:articleTitle | Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. | lld:pubmed |
| pubmed-article:18641082 | pubmed:affiliation | Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands. | lld:pubmed |
| pubmed-article:18641082 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18641082 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18641082 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18641082 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18641082 | lld:pubmed |
